Gong to Join Critical Care Steering Committee
Michelle Gong, MD
Michelle Gong, MD (Critical Care Medicine), Chief of Critical Care Research, has been invited to become a member of the US Critical Illness and Injury Trials Group (USCIITG) Steering Committee.
Dr. Gong joined the Department of Medicine as Director of Critical Care Research in 2009. Her research interests are in risk prognostication and outcomes studies of critical illnesses such as sepsis and acute respiratory distress syndrome (ARDS), and in better understanding the unique epidemiologic and ethical circumstances surrounding critical care research. She has been a past recipient of the National Institutes of Health's (NIH) Health Disparity Scholar Award and the Mentored Patient-Oriented Research Career Development Award, and is currently the recipient of NIH-supported investigator-initiated awards to examine both the potential role of early insulin therapy to modulate lung injury in sepsis, and the special issue of surrogate consents for research in incapacitated, critically ill patients.
USCIITG exists to facilitate collaboration among experts with the goal of promoting clinical trials in the critically ill or injured by fostering the development of evidence-based clinical protocols and the subsequent preparation of applications for funding to test specific hypotheses. Meetings are held annually at the National Institutes of Health (NIH) and also at critical illness and injury societal meetings.